Illumina, Inc. (ILU)
XSTU
Real-time Data
06:00 AM
Day's Range
184.7252 wk Range
77.93Overview - ILU - Illumina, Inc.
Key Statistics
Valuation
Enterprise Value
1.13B
P/E (Trailing)
‪34.78‬
PEG Ratio
‪-4.31‬
EV / EBITDA
‪0.77‬
Profitability
Profit Margin
‪66.08%‬
Operating Margin
‪27.33%‬
Return on Assets
‪12.79%‬
Return on Equity
‪31.21%‬
Ownership
Shares Outstanding
151.00M
Price stats
50-Day Avg
‪163.46‬
200-Day Avg
‪127.08‬
Peers - ILU - Illumina, Inc.
Peer Comparison
Compared with companies in Diagnostics & Research listed on XSTU.
- ILUXSTUIllumina, Inc.+50.05%52-week change29.79P/E (Trailing)‪66.08%‬Profit Margin
- NL0XSTUGrail, Inc.+58.79%52-week change-6.25P/E (Trailing)‪-236.94%‬Profit Margin
- 8YYXSTUCoro Energy plc+86.30%52-week change0.07P/E (Trailing)‪63.04%‬Profit Margin
- 0MEXSTUTwist Bioscience Corporation+80.50%52-week change-92.62P/E (Trailing)‪50.72%‬Profit Margin
- 12VXSTUVeracyte Inc.+49.99%52-week change54.75P/E (Trailing)‪70.10%‬Profit Margin
- 7CCXSTUCheck-Cap Ltd.+48.78%52-week change1.86P/E (Trailing)—Profit Margin
- WX8XSTUWuXi AppTec Co., Ltd.+46.51%52-week change2.46P/E (Trailing)‪47.63%‬Profit Margin
Profile Summary - ILU - Illumina, Inc.
About
Illumina, Inc. is a life sciences and diagnostics company that develops, manufactures, and markets tools and integrated systems for the analysis of genetic material. Its primary focus is on next-generation sequencing technologies, providing high-throughput and lower-throughput sequencing instruments, consumables, and…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
